decemb
novel
betacoronaviru
provision
name
novel
coronaviru
subsequ
offici
renam
sever
acut
respiratori
syndrom
coronaviru
intern
committe
taxonomi
virus
ictv
caus
coronaviru
diseas
covid
associ
cluster
respiratori
tract
infect
wuhan
hubei
provinc
china
rapidli
spread
across
contin
februari
accord
surveil
european
centr
diseas
prevent
control
ecdc
us
center
diseas
control
prevent
cdc
case
report
among
countri
five
main
contin
number
death
almost
occur
china
n
case
philippin
hong
kong
franc
taiwan
japan
current
report
fatal
rate
short
report
aim
summaris
clinic
aspect
novel
betacoronaviru
infect
possibl
manifest
februari
select
compar
studi
regard
first
outbreak
find
given
natur
review
ethic
approv
requir
search
perform
two
investig
sc
tl
total
studi
identifi
pubm
n
cochran
librari
n
two
investig
review
articl
initi
titl
abstract
detail
use
customis
data
abstract
form
studi
exclud
incorrect
subject
matter
duplic
review
studi
english
includ
twelv
studi
identifi
fulltext
review
contain
origin
data
patient
male
tabl
age
rang
year
interestingli
first
period
global
epidem
case
young
peopl
age
year
nevertheless
among
known
infect
subject
outsid
china
preval
male
age
distribut
time
diagnosi
resembl
chines
epidem
although
past
medic
histori
alway
avail
hypertens
report
underli
condit
mani
respect
case
seri
ren
et
al
wang
et
al
chen
et
al
describ
mostli
cardiovascular
cerebrovascular
diseas
popul
furthermor
ren
et
al
report
underli
chronic
liver
diseas
whole
popul
n
featur
differ
least
far
case
huang
et
al
wang
et
al
shown
rate
chronic
obstruct
pulmonari
diseas
copd
approxim
respect
subsequ
chen
et
al
report
rate
approxim
respiratori
system
diseas
differ
estim
copd
preval
differ
region
china
moreov
interstiti
lung
diseas
histori
smoke
bronchiectasi
asthma
underreport
diabet
first
mention
huang
et
al
repres
main
comorbid
cohort
thereaft
author
report
diabet
approxim
subject
furthermor
among
case
outsid
asia
holshu
et
al
mention
hypertriglyceridemia
sole
chronic
ill
first
us
case
hand
german
case
overal
healthi
patient
confirm
infect
mostli
respiratori
sign
symptom
fever
report
case
seri
avail
flank
cough
mostli
dri
tabl
dyspnoea
uncommon
report
entir
cohort
ren
et
al
n
signific
proport
patient
complain
gastrointestin
symptom
nausea
vomit
diarrhoea
also
appear
cours
ill
distinct
featur
holshu
et
al
meticul
describ
evolut
first
us
case
complain
first
respiratori
symptom
ie
dri
cough
follow
abdomin
discomfort
selflimit
nausea
vomit
diarrhoea
myalgia
fatigu
asian
case
seri
multipl
bilater
lobular
subsegment
area
consolid
bilater
groundglass
opac
main
report
radiolog
featur
patient
case
seri
report
huang
et
al
plain
chest
radiographi
cxr
comput
tomographi
ct
find
pneumonia
although
ct
best
method
defin
extens
typolog
lung
parenchyma
involv
cxr
mostli
employ
first
investig
probabl
associ
need
compli
infect
control
procedur
leukopenia
common
abnorm
report
subject
studi
huang
et
al
thrombocytopenia
occur
report
holshu
et
al
chen
et
al
rare
report
seri
although
low
platelet
count
found
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
nevertheless
abnorm
hepat
eg
slight
increas
aspart
aminotransferas
ast
alanin
aminotransferas
alt
level
muscl
eg
slight
increas
creatin
kinas
lactat
dehydrogenas
enzym
seen
earli
case
later
report
tabl
one
might
expect
creactiv
protein
crp
erythrocyt
sediment
rate
esr
frequent
abnorm
contrast
patient
normal
procalcitonin
pct
level
admiss
cohort
huang
et
al
patient
pct
level
ngml
interestingli
case
seri
wang
et
al
prolong
prothrombin
time
report
approxim
adult
one
larger
cohort
avail
huang
et
al
patient
superinfect
risk
increas
intens
care
intens
care
unit
icu
care
vs
icu
care
p
almost
patient
treat
empir
antibiot
coverag
acut
phase
furthermor
risk
acut
respiratori
distress
syndrom
without
specif
bacteri
superinfect
complic
clinic
cours
patient
larg
cohort
huang
et
al
case
increas
troponin
count
occur
five
patient
complain
acut
cardiac
injuri
find
requir
studi
assess
heart
tropism
cardiovascular
risk
infect
patient
acut
ill
chen
et
al
report
low
rate
fungal
isol
clinic
need
empir
antifung
treatment
one
case
candida
glabrata
three
case
c
albican
one
case
import
aspergillu
flavu
isol
moreov
author
report
lower
rate
bacteri
respiratori
isol
mostli
acinetobact
baumannii
klebsiella
pneumonia
accord
microbiolog
data
poor
repres
popul
followup
time
report
literatur
short
defin
real
burden
postvir
infecti
complic
first
wave
caus
death
despit
sever
ill
mild
case
wang
et
al
interestingli
review
underli
diseas
demograph
characterist
death
occur
wuhan
epidem
found
older
adult
year
present
shorter
period
first
symptom
death
compar
younger
person
rang
day
vs
rang
day
p
previous
report
betacoronavirus
confirm
increas
sever
elderli
coronaviru
ill
furthermor
accord
wang
et
al
develop
median
period
symptomat
phase
death
median
day
somewhat
similar
merscov
median
day
sarscov
median
day
tabl
daili
assess
real
extent
epidem
scientif
turmoil
tri
keep
learn
least
scientif
lesson
previou
epidem
sarscov
merscov
therefor
await
true
extent
new
diseas
featur
notabl
outsid
chines
land
lack
specif
clinic
featur
diagnost
microbiolog
challeng
eg
revers
transcript
pcr
rtpcr
nasal
rhinopharyng
swab
along
outbreak
occur
delay
peak
season
influenza
make
definit
difficult
task
one
hand
clinic
symptom
high
rate
fever
respiratori
symptom
resembl
previou
featur
coronaviru
infect
hand
system
symptom
chill
rigor
seen
respect
case
merscov
sarscov
epidem
respect
unusu
phenomenon
among
infect
usual
pattern
present
novel
coronaviru
quit
unspecif
similar
mani
viral
infect
comorbid
past
merscov
epidem
includ
cardiovascular
diseas
eg
hypertens
histori
smoke
diabet
although
number
chronic
ill
low
underreport
despit
probabl
far
precis
overview
high
rate
radiolog
clinic
suspici
pneumonia
report
review
cohort
patient
call
reflect
notabl
perspect
view
need
empir
antibiot
coverag
set
possibl
bacteri
superinfect
influenza
viru
outbreak
report
sarscov
epidem
increas
rate
methicillinresist
staphylococcu
aureu
mrsa
case
per
admiss
presar
period
sar
period
p
increas
rate
ventilatoracquir
pneumonia
icu
mostli
caus
mrsa
give
number
common
point
previou
coronaviru
infect
antimrsa
empir
treatment
need
consid
also
reduc
risk
superinfect
therefor
assess
risk
mrsa
difficulttotreat
bacteri
superinfect
pseudomona
aeruginosa
multidrugresist
gramneg
bacilli
colonis
accord
cardiovascular
comorbid
lung
abnorm
system
diseas
sever
pneumonia
risk
advers
event
drugrel
toxic
crucial
point
suspect
case
treatment
algorithm
propos
base
common
risk
factor
mrsa
andor
p
aeruginosa
fig
risk
fungal
coinfect
appear
low
despit
fact
viral
infect
influenza
larg
number
classic
risk
factor
eg
haematolog
patient
solidorgan
haematopoiet
stem
cell
transplant
recipi
hiv
patient
describ
favour
environ
invas
fungal
infect
especi
invas
pulmonari
aspergillosi
empir
antifung
treatment
consid
critic
patient
new
pulmonari
infiltr
superimpos
viral
pneumon
pattern
aim
confirm
diagnosi
invas
techniqu
andor
use
fungal
biomark
far
data
efficaci
specif
antivir
treatment
inconclus
current
seri
report
wide
rang
manag
option
holshu
et
al
resort
compassion
use
remdesivir
favour
outcom
hand
chen
et
al
popul
patient
describ
antivir
treatment
patient
median
durat
day
interquartil
rang
day
conclus
infecti
diseas
perspect
base
lesson
learn
previou
wellknown
coronaviru
outbreak
eg
merscov
sarscov
readi
outbreak
must
focu
attent
prompt
diagnosi
case
infect
control
procedur
isol
suspect
case
anticip
may
complic
evolut
cours
epidem
none
